Quick Answer
Senti Biosciences Holdings, Inc. reported Stockholders Equity of $5.59 million for fiscal year 2025.
Senti Biosciences Holdings, Inc. Stockholders Equity — Annual History
| Fiscal Year | Stockholders Equity | YoY Change |
|---|---|---|
| 2025 | $5.59M | -78.2% |
| 2024 | $25.65M | -61.7% |
| 2023 | $66.91M | -47.4% |
| 2022 | $127.26M | +214.2% |
| 2021 | -$111.46M | — |
| 2021 | $0.00 | +100.0% |
| 2020 | -$58.71M | — |
Quarterly Stockholders Equity
| Quarter Ending | Stockholders Equity | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $8.12M | -49.2% | -67.1% |
| June 30, 2025 | $24.65M | -44.2% | -34.9% |
| March 31, 2025 | $37.86M | -32.5% | +47.6% |
| December 31, 2024 | $25.65M | -61.7% | +60.4% |
| September 30, 2024 | $15.99M | -80.7% | -63.8% |
| June 30, 2024 | $44.15M | -54.7% | -21.3% |
| March 31, 2024 | $56.09M | -50.1% | -16.2% |
| December 31, 2023 | $66.91M | -47.4% | -19.3% |
- Senti Biosciences Holdings, Inc. showed a decrease of -78.2% in Stockholders Equity compared to the prior fiscal year.
- Over the 2020–2025 period, Senti Biosciences Holdings, Inc.’s stockholders equity has grown by 109.5% (from -$58.71 million to $5.59 million).
- The most recent figure is from Senti Biosciences Holdings, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 27, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: